Beatriz Ponte

ORCID: 0000-0003-4916-4375
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Development and Disorders
  • Retinal Diseases and Treatments
  • Glaucoma and retinal disorders
  • Retinal Imaging and Analysis
  • Neuroscience and Neural Engineering
  • Ocular Surface and Contact Lens
  • Ocular Oncology and Treatments
  • Corneal surgery and disorders
  • CRISPR and Genetic Engineering
  • Retinal and Macular Surgery
  • Corneal Surgery and Treatments
  • Retinoids in leukemia and cellular processes
  • Photoreceptor and optogenetics research
  • Ocular Disorders and Treatments
  • Virus-based gene therapy research
  • Cardiovascular Syncope and Autonomic Disorders
  • Parental Involvement in Education
  • Medical research and treatments
  • Educational Outcomes and Influences
  • RNA regulation and disease
  • Neuropeptides and Animal Physiology
  • Meningioma and schwannoma management
  • Pluripotent Stem Cells Research
  • Brain Metastases and Treatment
  • Mitochondrial Function and Pathology

Hospital Universitario Virgen Macarena
2016-2024

Instituto de Salud Carlos III
2019-2022

Ministry of Health
2019

Universidad de Sevilla
2019

Andalusian Health Service
2016-2018

Penn Presbyterian Medical Center
1987

University of Pennsylvania
1987

Felipe A. Medeiros Thomas R. Walters Miriam Kolko Michael Coote Marina Bejanian and 95 more Margot L. Goodkin Qiang Guo Jane Zhang Michael R. Robinson Robert N. Weinreb Ashish Agar Michael Coote Renuka Bathijia Lance Liu Tim Roberts Christoph Faschinger Clemens Vass Nathalie Collignon Ana Cláudia Alves Pereira Rubens Belfort de Mattos Fernando Justino Dantas M. J. Silva Fábio Nishimura Kanadani Leopoldo Magacho dos Santos Silva Tiago Prata Daniella Bach‐Holm Miriam Kolko Jimmy Lai Clement C. Tham György Bátor Lajos Szalczer Balázs Varsányi Eytan Z. Blumenthal Orna Geyer Shmuel Lavartovsky Tamar Pedut-Kloizman Nir Shoham-Hazon Silvio Lujan Benjamin Abela Robert Edward T. Ang Edgar U. Leuenberger Harvey S. Uy Maria Imelda R. Yap-Veloso Piotr Fryczkowski Piotr Jurowski Bartłomiej J. Kałużny Józef Kalużny Marta Misiuk‐Hojło Krystyna Raczyńska Wioletta Tomczyk-Dorozynska J Wasyluk S Zalewski Tomasz Żarnowski J. García–Sánchez R. Giménez-Gómez Elena Millà Griñó Alfonso Antón López Merce Guarro Miralles Javier Montero Moreno Vicente Polo Enrique Cervera Taulet Beatriz Ponte Yingying Chen Yuan‐Chieh Lee Louis Alpern Michael S. Berlin Jacob W. Brubaker Delmar R. Caldwell Andrew Camp Louis B. Cantor Ronald Caronia Charles J. Crane Douglas G. Day Eran Duzman John L Elfervig Shérif M. El-Harazi Richard Evans Ann C. Fisher William J. Flynn C. Stephen Foster R. E. P. Frenkel Raj Goyal Ronald L. Gross Paul J. Hartman William L. Haynes Gary Jerkins Janet Kim Max Kim Bradley Kwapiszeski Benjamin Lambright Christine L. Larsen James D. Lehmann Jeffrey Levenson Dwayne K. Logan Brian McMillan Joseph R. Martel Hylton R. Mayer Felipe A. Medeiros Sayoko E. Moroi Andrew L. Moyes

To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of 10- 15-μg bimatoprost implant in subjects with open-angle glaucoma (OAG) ocular hypertension (OHT) after initial repeated administrations.Randomized, 20-month, multicenter, subject- evaluator-masked, parallel-group, phase 3 clinical study.Adults OAG or OHT each eye, open iridocorneal angle inferiorly study eye baseline IOP (hour 0; 8 am) 22-32 mmHg washout.Study eyes received 10 μg (n = 198) 15 on day 1...

10.1016/j.ophtha.2020.06.018 article EN cc-by-nc-nd Ophthalmology 2020-06-13

Background: To characterize the phenotype and genotype of a rare syndrome associating posterior microphthalmos (PM), retinitis pigmentosa (RP), foveoschisis in consanguineous Spanish family.Methods: The study involved five family members, consisting three siblings their parents. All members underwent comprehensive eye examinations for best corrected visual acuity, axial length refractive error, electroretinography (ERG), fundus photography, retinal fluorescein angiography (FA), optical...

10.1080/13816810.2019.1633547 article EN Ophthalmic Genetics 2019-05-04

Currently, brachytherapy is the most commonly used therapeutic approach for uveal melanomas. Surgical resection by means of endoresection or exoresection an alternative approach. The present report recounts our experience over 15 years in treatment melanoma using a combined surgery with brachytherapy. This single-center observational retrospective cohort study which we describe clinical outcomes, complications and survival 35 cases iris ciliary body after combination alone. Local tumor was...

10.3390/jcm11061616 article EN Journal of Clinical Medicine 2022-03-15

Retinitis pigmentosa (RP) is an inherited retinal degenerative disease. Mutations in EYS have been associated with autosomal recessive RP. The human iPS cell line, CABi002-A, derived from peripheral blood mononuclear cells a patient carrying heterozygous double mutation gene was generated by non-integrative reprogramming technology, using hOCT3/4, hSOX2, hc-MYC and hKLF4 factors. Pluripotency differentiation capacity were assessed immunocytochemistry RT-PCR. This iPSC line can be further...

10.1016/j.scr.2018.11.002 article EN cc-by Stem Cell Research 2018-11-15

Age-related macular degeneration (AMD) is the leading cause of adult blindness in developed countries and characterized by progressive macula, central region retina. A human induced pluripotent stem cell (hiPSC) line was derived from peripheral blood mononuclear cells (PBMCs) a patient with clinical diagnosis dry AMD carrying CFH Y402H polymorphism. Sendai virus using for reprogramming differentiation capacity were assessed immunocytochemistry RT-PCR.

10.1016/j.scr.2019.101473 article EN cc-by-nc-nd Stem Cell Research 2019-05-29

Retinal dystrophies associated to mutations in the CRB1 gene comprise a wide array of clinical presentations. A blood sample from patient with family history CRB1-retinal dystrophy was used prepare iPSC line ESi082-A. The genotype donor, affected perifoveal-bilateral macular includes one frameshift deletion and hypomorphic allele. ESi082-A cell has been characterized for pluripotency will be retinal cellular models study dysfunction leading disease.

10.1016/j.scr.2021.102301 article EN cc-by-nc-nd Stem Cell Research 2021-03-19

To describe the clinical and genetic characteristics (novel mutation in BEST1 gene) of a Spanish patient with autosomal recessive bestrophinopathy (ARB).The detailed ophthalmological examination included best corrected visual acuity (BCVA), color autofluorescence photography, fluorescein angiography, optical coherence tomography, electrophysiology tests. A next-generation sequencing (NGS) strategy was applied to index patient, then sequenced an Illumina NextSeq500 system.A 55-year-old male...

10.1177/11206721211010615 article EN European Journal of Ophthalmology 2021-04-19

PRPF31 gene codes for a ubiquitously expressed splicing factor but mutations affect exclusively the retina, producing progressive death of photoreceptor cells. We have identified novel mutation in patient with autosomal dominant retinitis pigmentosa. A blood sample was obtained and mononuclear cells were reprogrammed using non-integrative Sendai virus to generate cell line CABi001-A. The iPSC has been characterized pluripotency differentiation capacity will be differentiated toward...

10.1016/j.scr.2019.101426 article EN cc-by-nc-nd Stem Cell Research 2019-03-20
Coming Soon ...